These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 8441429

  • 1. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H.
    Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906
    [Abstract] [Full Text] [Related]

  • 3. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G.
    Prog Clin Biol Res; 1994 May 01; 385():137-45. PubMed ID: 7972205
    [Abstract] [Full Text] [Related]

  • 4. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.
    Cancer Res; 1992 Mar 01; 52(5):1364-8. PubMed ID: 1737399
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
    Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, Brodeur GM.
    Cancer Res; 1995 Apr 15; 55(8):1792-7. PubMed ID: 7712489
    [Abstract] [Full Text] [Related]

  • 6. High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas.
    Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MS, Zhao H, Cnaan A, Sakiyama S.
    Cancer Res; 1997 Oct 15; 57(20):4578-84. PubMed ID: 9377572
    [Abstract] [Full Text] [Related]

  • 7. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S, Ohira M, Isogai E, Nakada K, Nakagawara A.
    Int J Oncol; 2004 Jun 15; 24(6):1457-66. PubMed ID: 15138588
    [Abstract] [Full Text] [Related]

  • 8. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N.
    N Engl J Med; 1999 Jun 24; 340(25):1954-61. PubMed ID: 10379019
    [Abstract] [Full Text] [Related]

  • 9. Expression of TrkC in favorable human neuroblastomas.
    Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM.
    Oncogene; 1996 Jan 04; 12(1):37-41. PubMed ID: 8552397
    [Abstract] [Full Text] [Related]

  • 10. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
    Azar CG, Scavarda NJ, Nakagawara A, Brodeur GM.
    Prog Clin Biol Res; 1994 Jan 04; 385():169-75. PubMed ID: 7972209
    [Abstract] [Full Text] [Related]

  • 11. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.
    Cancer; 2004 Oct 15; 101(8):1873-81. PubMed ID: 15386308
    [Abstract] [Full Text] [Related]

  • 12. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
    Lavenius E, Gestblom C, Johansson I, Nånberg E, Påhlman S.
    Cell Growth Differ; 1995 Jun 15; 6(6):727-36. PubMed ID: 7669728
    [Abstract] [Full Text] [Related]

  • 13. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R.
    N Engl J Med; 1996 Jan 25; 334(4):225-30. PubMed ID: 8531999
    [Abstract] [Full Text] [Related]

  • 14. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
    Tanaka T, Hiyama E, Sugimoto T, Sawada T, Tanabe M, Ida N.
    Cancer; 1995 Sep 15; 76(6):1086-95. PubMed ID: 8625212
    [Abstract] [Full Text] [Related]

  • 15. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
    Nakagawara A, Ikeda K, Yokoyama T, Tsuda T, Higashi K.
    Surgery; 1988 Jul 15; 104(1):34-40. PubMed ID: 3388178
    [Abstract] [Full Text] [Related]

  • 16. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.
    Clin Cancer Res; 1997 Oct 15; 3(10):1699-706. PubMed ID: 9815553
    [Abstract] [Full Text] [Related]

  • 17. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R, Ambros PF, Urban C, Ambros IM, Fink FM, Zoubek A, Grienberger H, Schmitt K, Kerbl R, Horcher E, Amann G, Höfler G, Heinzl H, Gadner H, Mutz I.
    Klin Padiatr; 1996 Oct 15; 208(4):210-20. PubMed ID: 8926686
    [Abstract] [Full Text] [Related]

  • 18. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
    Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D.
    N Engl J Med; 1985 Oct 31; 313(18):1111-6. PubMed ID: 4047115
    [Abstract] [Full Text] [Related]

  • 19. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, Nose Y, Kuwano M.
    Cancer Res; 1990 May 15; 50(10):3043-7. PubMed ID: 2185879
    [Abstract] [Full Text] [Related]

  • 20. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
    Stephan H, Zakrzewski JL, Bölöni R, Grasemann C, Lohmann DR, Eggert A.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):218-22. PubMed ID: 17973327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.